A Phase 3 interventional study of Acetaminophen and Placebo Control in Pain, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.. Completed at 1 site in United States. Open to participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2012-05-28.
Sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (formerly part of Johnson & Johnson) · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 137 studies testing acetaminophen in Pain — 5 open to participants now, 5 under way, none of them phase 3. Acetaminophen · Pain.
Among the 137 studies testing acetaminophen in Pain, this one is the 8th largest by enrollment, is one of 6 that started in 2010, is one of 22 in phase 3, and was the 35th registered.
10,075 studies on the registry are indexed under Pain; 1,649 are open to participants now.
Browse Pain studies →5 of the 137 studies testing acetaminophen in Pain are open now, in 3 countries. Recruiting first, the newest first:
McGill University Health Centre/Research Institute of the McGill University Health Centre · Sites in Canada
Ages 18+
Horizon Health Network · Sites in Canada
Ages 19+
University of Gaziantep · Sites in Turkey
Ages 18–75
Western Galilee Hospital-Nahariya · Sites in Israel
Ages 18–45 · Women only · Healthy volunteers
Baskent University · Sites in Turkey
Ages 18–65 · Healthy volunteers
By country, each count listing its studies:
Acetaminophen: first FDA approval 1968 (NEOPAP). What it is approved for, and how studies give it, is on its page →
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 433 (47%) stop at 75 or younger; 145 take children under 18; 220 take healthy volunteers.
This study: 16 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
137 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 18 · Phase 3 25 · Phase 4 67
First in 2003; this study’s year is marked. 6 started in 2010.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 540 is above the median of 66 across 8,511 interventional studies indexed under Pain.
Median enrollment 95 across the 137 interventional studies. Of the 115 that completed or were terminated, 53 (46%) have results posted.
This tab as a report to print or save as PDF → With an account.
39 of 137 have an industry lead sponsor. The 10 most frequent:
This study is registered under McNeil Consumer Healthcare Division of McNEIL-PPC, Inc., one of the names counted as Johnson & Johnson. Under that name alone:
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. is the lead sponsor of 6 studies on the registry; none are open to participants now.
104 studies in Pain by Johnson & Johnson: none open now, none under way, none of them phase 3. Of 99 finished, 32 (32%) have results posted.
Among the 104 studies in Pain by Johnson & Johnson, this one is the 14th largest by enrollment of the 88 interventional ones that give a count, is one of 9 that started in 2010, is one of 40 in phase 3, and was the 69th registered.
Johnson & Johnson’s Pain studies by the year they started, since 1986.
4 of the studies testing acetaminophen in Pain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07512297University of GaziantepPain Control During ESWL Using Non-Opioid Analgesics | 2027-01-01 |
| NCT07368738Horizon Health NetworkIntravenous Acetaminophen and Ketorolac for Pain Management During Extracorporeal Shockwave Lithotripsy | 2027-04 |
| NCT06613178McGill University Health Centre/Research Institute of the McGill University Health CentreIntravenous Acetaminophen After Cardiac Surgery - Definitive Study | 2027-07-01 |
| NCT07536425Western Galilee Hospital-NahariyaPreoperative Indomethacin and Paracetamol for Pain Management During Oocyte Retrieval in IVF Patients | 2027-10-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 137 studies testing acetaminophen in Pain, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Johnson & Johnson’s 104 in Pain:
This tab as a report to print or save as PDF → With an account.
The objective of this study is to evaluate the safety and efficacy of acetaminophen 650 mg and acetaminophen 1000 mg in dental surgery.
This trial is to assess the relative efficacy of acetaminophen 1000 mg versus acetaminophen 650 mg over a six-hour period, in subjects experiencing at least moderate post-operative dental pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
1000 mg Acetaminophen Caplet
Drug: Acetaminophen
650 mg Acetaminophen Caplet
Drug: Acetaminophen
0 mg Acetaminophen Caplet
Drug: Placebo Control
Acetaminophen Caplet - single dose
Also known as: Tylenol
0 mg Caplet - single dose
Also known as: Control
Overall Analgesic Efficacy - Sum of Pain Intensity Difference and Pain Relief Scores Over Six Hours (SPRID6)
Weighted Sum of Pain Intensity Difference and Pain Relief Scores Over Six Hours (SPRID6) - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief. For SPRID6, the total possible minimum value is -300 (worst) and the total possible maximum value is 1200 (best). The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
Time frame: 6 Hours
Sum of Pain Intensity Difference Over Six Hours (SPID6)
Weighted Sum of the Pain Intensity Difference from Baseline Over Six Hours (SPID6) - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain. The total possible minimum value is -300 (worst) and the total possible maximum value is 600 (best). The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
Time frame: 6 Hours
Sum of Pain Relief Scores Over Six Hours (TOTPAR6)
Weighted Sum of the Pain Relief Scores Over Six Hours (TOTPAR6) - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief. The total possible minimum value is 0 (worst) and the total possible maximum value is 600 (best). The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
Time frame: 6 Hours
Pain Intensity Difference (PID) at 15 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 15 Minutes
Pain Intensity Difference (PID) at 30 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 30 Minutes
Pain Intensity Difference (PID) at 45 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 45 Minutes
Pain Intensity Difference (PID) at 60 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 60 Minutes
Pain Intensity Difference (PID) at 75 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time Point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 75 Minutes
Pain Intensity Difference (PID) at 90 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 90 Minutes
Pain Intensity Difference (PID) at 120 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 120 Minutes
Pain Intensity Difference (PID) at 180 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 180 Minutes
Pain Intensity Difference (PID) at 240 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 240 Minutes
Pain Intensity Difference (PID) at 300 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 300 Minutes
Pain Intensity Difference (PID) at 360 Minutes
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
Time frame: 360 Minutes
Pain Relief (PAR) Scores at 15 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 15 Minutes
Pain Relief (PAR) Scores at 30 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 30 Minutes
Pain Relief (PAR) Scores at 45 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 45 Minutes
Pain Relief (PAR) Scores at 60 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 60 Minutes
Pain Relief (PAR) Scores at 75 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 75 Minutes
Pain Relief (PAR) Scores at 90 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 90 Minutes
Pain Relief (PAR) Scores at 120 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 120 Minutes
Pain Relief (PAR) Scores at 180 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 180 Minutes
Pain Relief (PAR) Scores at 240 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 240 Minutes
Pain Relief (PAR) Scores at 300 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 300 Minutes
Pain Relief (PAR) Scores at 360 Minutes
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
Time frame: 360 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 15 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 15 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 30 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 30 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 45 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 45 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 60 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 60 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 75 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 75 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 90 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 90 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 120 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 120 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 180 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 180 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 240 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 240 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 300 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 300 Minutes
Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 360 Minutes
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
Time frame: 360 Minutes
Time to Meaningful Pain Relief
Minutes until meaningful pain relief was achieved. A stopwatch was provided to the subject after ingestion of the study medication. The subject was instructed to stop the stopwatch when the relief from the starting pain was meaningful to them.
Time frame: within 6 Hours
Time to Confirmed Perceptible Pain Relief
Minutes until confirmed perceptible pain relief was achieved. A stopwatch was provided to the subject after ingestion of the study medication. The subject was instructed to stop the stopwatch when they first began to feel any pain relieving effect whatsoever of the drug, that was when they first felt any pain relief. It did not necessarily mean they felt completely better, although they might have, but when they first felt any difference in the pain.
Time frame: within 6 Hours
Duration of Analgesia - Time to Rescue
Minutes until rescue medication was given.
Time frame: within 6 Hours
Rescue Rates Through Four Hours
Percentage of subjects using rescue medication.
Time frame: through 4 Hours
Rescue Rates Through Six Hours
Percentage of subjects using rescue medication.
Time frame: through 6 Hours
Percentage of Subjects With >50% of the Maximum Possible TOTPAR6 Score
Percentage of Subjects with \>50% of the Maximum Possible TOTPAR6 Score - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 600 so \>50% is \>300 out of 600
Time frame: 6 Hours
Patient Global Evaluation
Patient Assessment of the Pain Medication - Number of Subjects rating the medication they received as a pain reliever on a score of 0-4, where 0=poor, 1=fair, 2=good, 3=very good, 4=excellent
Time frame: 6 Hours
| Milestone | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Started | 239 | 241 | 60 |
| Completed | 239 | 241 | 60 |
| Not completed | 0 | 0 | 0 |
Weighted Sum of Pain Intensity Difference and Pain Relief Scores Over Six Hours (SPRID6) - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief. For SPRID6, the total possible minimum value is -300 (worst) and the total possible maximum value is 1200 (best). The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Overall Analgesic Efficacy - Sum of Pain Intensity Difference and Pain Relief Scores Over Six Hours (SPRID6) | 529.4 ± 22.31 | 427.3 ± 22.21 | 60.0 ± 44.51 |
Weighted Sum of the Pain Intensity Difference from Baseline Over Six Hours (SPID6) - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain. The total possible minimum value is -300 (worst) and the total possible maximum value is 600 (best). The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference Over Six Hours (SPID6) | 222.5 ± 10.49 | 174.3 ± 10.44 | -4.2 ± 20.93 |
Weighted Sum of the Pain Relief Scores Over Six Hours (TOTPAR6) - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief. The total possible minimum value is 0 (worst) and the total possible maximum value is 600 (best). The weights used in the calculation of weighted sums were equal to the elapsed time (hour) between the time point of interest and the preceding time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Relief Scores Over Six Hours (TOTPAR6) | 306.9 ± 12.02 | 253.0 ± 11.96 | 64.3 ± 23.98 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 15 Minutes | 5.6 ± 0.92 | 6.9 ± 0.91 | 1.3 ± 1.83 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 30 Minutes | 21.3 ± 1.48 | 21.5 ± 1.47 | 0.5 ± 2.95 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 45 Minutes | 33.9 ± 1.71 | 32.8 ± 1.71 | 0.2 ± 3.42 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 60 Minutes | 40.4 ± 1.82 | 36.6 ± 1.81 | -0.1 ± 3.62 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time Point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 75 Minutes | 43.1 ± 1.88 | 37.6 ± 1.87 | -0.9 ± 3.74 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 90 Minutes | 44.4 ± 1.93 | 38.0 ± 1.92 | -0.6 ± 3.85 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 120 Minutes | 44.8 ± 2.00 | 35.7 ± 1.99 | -2.7 ± 3.99 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 180 Minutes | 40.8 ± 2.03 | 31.9 ± 2.02 | -2.6 ± 4.05 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 240 Minutes | 40.8 ± 2.11 | 30.3 ± 2.10 | -1.1 ± 4.20 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 300 Minutes | 37.9 ± 2.17 | 27.1 ± 2.16 | -0.1 ± 4.32 |
Pain Intensity Difference (PID) from Baseline at Each Assessment Time point - pain intensity was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain with a highest possible score of 100. The pain intensity difference was calculated at each time point as the pain intensity score at baseline minus the pain intensity score at the stated time point.
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Intensity Difference (PID) at 360 Minutes | 33.4 ± 2.19 | 23.8 ± 2.18 | 1.0 ± 4.37 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 15 Minutes | 8.3 ± 1.09 | 9.4 ± 1.09 | 3.0 ± 2.18 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 30 Minutes | 29.6 ± 1.84 | 29.9 ± 1.83 | 4.8 ± 3.66 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 45 Minutes | 46.1 ± 2.10 | 44.8 ± 2.09 | 7.9 ± 4.18 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 60 Minutes | 54.4 ± 2.16 | 50.1 ± 2.15 | 8.3 ± 4.30 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 75 Minutes | 58.0 ± 2.18 | 52.0 ± 2.17 | 8.4 ± 4.35 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 90 Minutes | 59.9 ± 2.22 | 53.1 ± 2.21 | 10.1 ± 4.43 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 120 Minutes | 60.3 ± 2.25 | 50.8 ± 2.24 | 8.0 ± 4.49 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 180 Minutes | 56.3 ± 2.31 | 46.3 ± 2.30 | 9.5 ± 4.61 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 240 Minutes | 56.2 ± 2.41 | 44.3 ± 2.40 | 12.3 ± 4.81 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 300 Minutes | 52.2 ± 2.49 | 40.5 ± 2.48 | 13.8 ± 4.97 |
Pain Relief Scores at each Assessment Timepoint - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 100
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Pain Relief (PAR) Scores at 360 Minutes | 48.0 ± 2.51 | 36.6 ± 2.50 | 14.0 ± 5.02 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 15 Minutes | 13.9 ± 1.95 | 16.4 ± 1.94 | 4.2 ± 3.89 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 30 Minutes | 50.9 ± 3.26 | 51.3 ± 3.24 | 5.2 ± 6.50 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 45 Minutes | 80.0 ± 3.76 | 77.6 ± 3.74 | 8.1 ± 7.49 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 60 Minutes | 94.9 ± 3.92 | 86.7 ± 3.90 | 8.2 ± 7.81 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 75 Minutes | 101.1 ± 4.00 | 89.6 ± 3.99 | 7.4 ± 7.99 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 90 Minutes | 104.2 ± 4.10 | 91.2 ± 4.08 | 9.4 ± 8.18 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 120 Minutes | 105.1 ± 4.20 | 86.5 ± 4.18 | 5.3 ± 8.38 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 180 Minutes | 97.1 ± 4.29 | 78.2 ± 4.27 | 6.9 ± 8.56 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 240 Minutes | 97.0 ± 4.47 | 74.6 ± 4.46 | 11.2 ± 8.93 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 300 Minutes | 90.1 ± 4.62 | 67.6 ± 4.60 | 13.7 ± 9.22 |
Sum of PID and PAR Scores (PRID) at each Assessment Time point - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief
| units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Sum of Pain Intensity Difference and Pain Relief Scores (PRID) at 360 Minutes | 81.4 ± 4.66 | 60.4 ± 4.64 | 15.0 ± 9.31 |
Minutes until meaningful pain relief was achieved. A stopwatch was provided to the subject after ingestion of the study medication. The subject was instructed to stop the stopwatch when the relief from the starting pain was meaningful to them.
| Minutes | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Time to Meaningful Pain Relief | 53.7 (9.3 to 360) | 56.1 (15.9 to 360) | NA (NA to NA) |
Minutes until confirmed perceptible pain relief was achieved. A stopwatch was provided to the subject after ingestion of the study medication. The subject was instructed to stop the stopwatch when they first began to feel any pain relieving effect whatsoever of the drug, that was when they first felt any pain relief. It did not necessarily mean they felt completely better, although they might have, but when they first felt any difference in the pain.
| Minutes | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Time to Confirmed Perceptible Pain Relief | 22.2 (3.8 to 360) | 22.2 (3.8 to 360) | NA (NA to NA) |
Minutes until rescue medication was given.
| Minutes | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Duration of Analgesia - Time to Rescue | NA (NA to NA) | NA (NA to NA) | 99.5 (92 to 360) |
Percentage of subjects using rescue medication.
| Percentage of Participants | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Rescue Rates Through Four Hours | 20.1 | 32.4 | 80.0 |
Percentage of subjects using rescue medication.
| Percentage of Participants | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Rescue Rates Through Six Hours | 29.3 | 45.6 | 80.0 |
Percentage of Subjects with \>50% of the Maximum Possible TOTPAR6 Score - pain relief was evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no relief and 100 = complete relief with a highest possible score of 600 so \>50% is \>300 out of 600
| Percentage of Participants | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Percentage of Subjects With >50% of the Maximum Possible TOTPAR6 Score | 56.9 | 44.4 | 6.7 |
Patient Assessment of the Pain Medication - Number of Subjects rating the medication they received as a pain reliever on a score of 0-4, where 0=poor, 1=fair, 2=good, 3=very good, 4=excellent
| Units on a scale | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| Patient Global Evaluation | 2.28 ± 0.073 | 1.95 ± 0.073 | 0.60 ± 0.146 |
Collected over 6 Hours (+30 days for Serious Adverse Events). Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| ACE-1000 | — | 0/239 (0%) | 45/239 (18.8%) |
| ACE-650 | — | 0/241 (0%) | 42/241 (17.4%) |
| ACE-0 | — | 0/60 (0%) | 13/60 (21.7%) |
| Event | ACE-1000 | ACE-650 | ACE-0 |
|---|---|---|---|
| NauseaGastrointestinal disorders | 29/239 | 26/241 | 9/60 |
| VomitingGastrointestinal disorders | 11/239 | 11/241 | 4/60 |
| DizzinessNervous system disorders | 10/239 | 8/241 | 4/60 |
| Age Continuous(years) | ACE-1000 | ACE-650 | ACE-0 | Total |
|---|---|---|---|---|
| Mean | 18.5 ± 2.24 | 18.3 ± 1.96 | 18.1 ± 2.02 | 18.4 ± 2.09 |
| Sex: Female, Male(Participants) | ACE-1000 | ACE-650 | ACE-0 | Total |
|---|---|---|---|---|
| Female | 131 | 120 | 31 | 282 |
| Male | 108 | 121 | 29 | 258 |
| Region of Enrollment(participants) | ACE-1000 | ACE-650 | ACE-0 | Total |
|---|---|---|---|---|
| United States | 239 | 241 | 60 | 540 |
The record gives a start of Jun 2010, a primary completion of Jan 2011 and a completion of Jan 2011. It does not say whether these dates are actual or estimated.
Results were first posted in May 2012, 1 year 4 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Acetaminophen
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. →